Guiding axes for drug safety management of pharmacovigilance centres during the COVID-19 era

The COVID-19 pandemic presents several challenges to the organisation and workflow of pharmacovigilance centres as a result of the massive increase in reports, the need for quick detection, processing and reporting of safety issues and the management of these within the context of lack of complete i...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferreira-da-Silva, Renato, Ribeiro-Vaz, Inês, Morato, Manuela, Polónia, Jorge Junqueira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8170628/
https://www.ncbi.nlm.nih.gov/pubmed/34076805
http://dx.doi.org/10.1007/s11096-021-01289-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8170628/
https://www.ncbi.nlm.nih.gov/pubmed/34076805
http://dx.doi.org/10.1007/s11096-021-01289-0

Ejemplares similares